Tonix Pharmaceuticals
TNXP
15 hedge funds and large institutions have $85.6M invested in Tonix Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
65% more capital invested
Capital invested by funds: $52M → $85.6M (+$33.6M)
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
25% more funds holding
Funds holding: 12 → 15 (+3)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$21.3M |
| 2 |
State Street
Boston,
Massachusetts
|
+$5.88M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.94M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$2.94M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$2.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.47M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.01M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$776K |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$735K |
| 5 |
Millennium Management
New York
|
-$735K |
TNXP Hedge Fund Activity: Q2 2021 in Review
15 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q2 2021, worth a combined $85.6M — up 65% from $52M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new TNXP positions and 5 closed out — a net gain of 3 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was BlackRock, adding an estimated $21.3M. The largest seller was Renaissance Technologies, cutting an estimated $1.47M.
- 15 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q2 2021, up from 12 in Q1 2021.
- Funds reported $85.6M of Tonix Pharmaceuticals stock for Q2 2021, up 65% quarter-over-quarter.
- 8 funds opened new Tonix Pharmaceuticals positions in Q2 2021 and 5 closed out, a net change of +3 holders.
- The largest Tonix Pharmaceuticals buyer in Q2 2021 was BlackRock, an estimated $21.3M added.
- The largest Tonix Pharmaceuticals seller in Q2 2021 was Renaissance Technologies, an estimated $1.47M sold.
Based on aggregated 13F filings for Q2 2021.